Naringin activates semaphorin 3A to ameliorate TGF‐β‐induced endothelial‐to‐mesenchymal transition related to atrial fibrillation
Journal of Cellular Physiology · 2024
DOI: 10.1002/jcp.31248 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular Physiology, 2024. Verfasst von Ying-Ju Lai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Department, Chang-Gung Memorial Hospital, Tao-Yuan, Taiwan. Hauptthemen laut MEDLINE: Atrial Fibrillation, Cell Proliferation, Endothelial Cells, Epithelial-Mesenchymal Transition. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Ministry of Science and Technology, Taiwan, Chang Gung Medical Research Program.
Abstract (Originalsprache)
The loss of semaphorin 3A (Sema3A), which is related to endothelial‐to‐mesenchymal transition (EndMT) in atrial fibrosis, is implicated in the pathogenesis of atrial fibrillation (AF). To explore the mechanisms by which EndMT affects atrial fibrosis and assess the potential of a Sema3A activator (naringin) to prevent atrial fibrosis by targeting transforming growth factor‐beta (TGF‐β)‐induced EndMT, we used human atria, isolated human atrial endocardial endothelial cells (AEECs), and used transgenic mice expressing TGF‐β specifically in cardiac tissues (TGF‐β transgenic mice). We evaluated an EndMT marker (Twist), a proliferation marker (proliferating cell nuclear antigen; PCNA), and an endothelial cell (EC) marker (CD31) through triple immunohistochemistry and confirmed that both EndMT and EC proliferation contribute to atrial endocardial fibrosis during AF in TGF‐β transgenic mice and AF patient tissue sections. Additionally, we investigated the impact of naringin on EndMT and EC proliferation in AEECs and atrial fibroblasts. Naringin exhibited an antiproliferative effect, to which AEECs were more responsive. Subsequently, we downregulated Sema3A in AEECs using small interfering RNA to clarify a correlation between the reduction in Sema3A and the elevation of EndMT markers. Naringin treatment induced the expression of Sema3A and a concurrent decrease in EndMT markers. Furthermore, naringin administration ameliorated AF and endocardial fibrosis in TGF‐β transgenic mice by stimulating Sema3A expression, inhibiting EndMT markers, reducing atrial fibrosis, and lowering AF vulnerability. This suggests therapeutic potential for naringin in AF treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiovascular Department, Chang-Gung Memorial Hospital, Tao-Yuan, Taiwan.
- Department of Respiratory Therapy, College of Medicine, Chang Gung University, Tao-Yuan, Taiwan.
- Department of Respiratory Care, Chang-Gung University of Science and Technology, Chia-Yi, Puzi, Taiwan.
- Department of Medicine, College of Medicine, Chang Gung University Tao-Yuan, Tao-Yuan, Taiwan.
- Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang-Gung University Tao-Yuan, Tao-Yuan, Taiwan.
- Department of Surgery, Division of Cardiovascular Surgery, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
ORCID-Profile: Ying-Ju Lai, Yung-Hsin Yeh
Förderung
- Ministry of Science and Technology, Taiwan
- Chang Gung Medical Research Program
Zitieren
APA
Lai, Y. J., Chang, S. H., Tung, Y. C., Chang, G. J., Almeida, C., Chen, W. J., Yeh, Y. H., & Tsai, F. C. (2024). Naringin activates semaphorin 3A to ameliorate TGF‐β‐induced endothelial‐to‐mesenchymal transition related to atrial fibrillation. Journal of Cellular Physiology. https://doi.org/10.1002/jcp.31248
Vancouver
Lai YJ, Chang SH, Tung YC, Chang GJ, Almeida C, Chen WJ, et al. Naringin activates semaphorin 3A to ameliorate TGF‐β‐induced endothelial‐to‐mesenchymal transition related to atrial fibrillation. Journal of Cellular Physiology. 2024. doi:10.1002/jcp.31248
BibTeX
@article{Lai2024,
author = {Lai, Ying-Ju and Chang, Shang-Hung and Tung, Ying-Chang and Chang, Gwo-Jyh and Almeida, Celina De and Chen, Wei-Jan and Yeh, Yung-Hsin and Tsai, Feng-Chun},
title = {Naringin activates semaphorin 3A to ameliorate TGF‐β‐induced endothelial‐to‐mesenchymal transition related to atrial fibrillation},
journal = {Journal of Cellular Physiology},
year = {2024},
doi = {10.1002/jcp.31248}
}
EUVIMED